Rheumatoid Arthritis Treatment Sarilumab Under Review


The FDA has accepted for review Sanofi and Regeneron Pharmaceuticals' biologics license application for sarilumab.

The FDA has accepted for review Sanofi and Regeneron Pharmaceuticals’ biologics license application for sarilumab.

This investigational, human monoclonal antibody targets the IL-6 receptor to treat moderate-to-severe rheumatoid arthritis.

The application submitted for review to the FDA includes data involving around 2500 adults with moderate-to-severe rheumatoid arthritis who did not respond well to previous treatment regimens.

The data spans 7 studies from the SARIL-RA phase 3 program.

Ongoing clinical programs are testing sarilumab for its safety and efficacy either by itself or in combination with disease-modifying anti-rheumatic drugs including methotrexate.

Sanofi and Regeneron last presented information from the SARIL-RA phase 3 studies back in November 2015. Data showed that the product could significantly improve the signs, symptoms, and physical function of patients with rheumatoid arthritis.

"Rheumatoid arthritis can be a debilitating disease that has a significant impact on a patient, and despite the availability of a wide range of treatments, new agents are still needed to address unmet patient needs including failure to respond to therapy," said lead study author Roy Fleischmann, clinical professor in the Department of Internal Medicine at the University of Texas Southwestern Medical Center, in a press release. "These data suggest that sarilumab, if approved, may be a potential option for patients with moderate-to-severe RA [rheumatoid arthritis]."

The target action date set is October 30, 2016.

Related Videos
Image credit:  Gorodenkoff | stock.adobe.com
Sun Screen, Photosensitivity, Pharmacy | Image Credit: sosiukin - stock.adobe.com
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny - stock.adobe.com
Various healthy foods -- Image credit: New Africa | stock.adobe.com
LGBTQIA+ pride -- Image credit: lazyllama | stock.adobe.com
Modern pharmacy building facade with large window showcasing the interior, as seen from the street view, promoting a welcoming atmosphere for customers. Frontal view. Generative AI - Image credit: Karrrtinki | stock.adobe.com
Close up hands of helping hands elderly home care. Mother and daughter. Mental health and elderly care concept - Image credit:  ipopba | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.